FOXK1 inhibitors belong to a class of chemical compounds designed to specifically target and impede the activity of the Forkhead box protein K1 (FOXK1). FOXK1 is a transcription factor, playing a crucial role in the regulation of various cellular processes, including cell cycle progression, DNA repair, and apoptosis. This protein is recognized for its involvement in maintaining genomic stability and modulating gene expression patterns, making it an attractive target for intervention.
The development of FOXK1 inhibitors is driven by the quest to gain a deeper understanding of the intricate molecular mechanisms underlying cellular functions and to explore potential applications in manipulating these processes.FOXK1 inhibitors often exhibit a high degree of specificity, interacting selectively with the FOXK1 protein to disrupt its normal function. Researchers employ a variety of synthetic strategies to design these inhibitors, focusing on small molecules that can effectively bind to the active sites of FOXK1, thereby disrupting its interaction with DNA or other regulatory proteins. This targeted approach aims to influence the downstream signaling pathways controlled by FOXK1, ultimately altering the cellular response to various stimuli.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine can inhibit FOXK1 by targeting all protein kinases, including the FOXK family. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin can inhibit mTOR signaling, which in turn suppresses FOXK1 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can reduce FOXK1 activity indirectly by suppressing PI3K/AKT pathway. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that indirectly affects FOXK1 by modifying histone acetylation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK and can decrease FOXK1 activity by disrupting JNK signaling pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, thus can reduce FOXK1 activity by disrupting p38 MAPK signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that can reduce the activity of FOXK1 by suppressing the ERK pathway. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
Flavopiridol can inhibit CDK9, which in turn can decrease FOXK1 transcription. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits PI3K, leading to the suppression of FOXK1 activity. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Nutlin-3 can inhibit the interaction between MDM2 and p53, indirectly impacting FOXK1. | ||||||